Measuring serum melatonin in epidemiologic studies.

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Ann W HsingLisa W Chu

Abstract

Epidemiologic data on serum melatonin, a marker of circadian rhythms, and cancer are sparse due largely to the lack of reliable assays with high sensitivity to detect relatively low melatonin levels in serum collected during daylight, as commonly available in most epidemiologic studies. To help expand epidemiologic research on melatonin, we assessed the reproducibility and refined a currently available melatonin RIA, and evaluated its application to epidemiologic investigations by characterizing melatonin levels in serum, urine, and/or plasma in 135 men from several ethnic groups. Reproducibility was high for the standard 1.0-mL serum [mean coefficient of variation (CV), 6.9%; intraclass correlation coefficient (ICC), 97.4%; n = 2 serum pools in triplicate] and urine-based (mean CV, 3.5%; ICC, 99.9%) assays. Reproducibility for the 0.5-mL refined-serum assay was equally good (mean CV, 6.6%; ICC, 99.0%). There was a positive correlation between morning serum melatonin and 6-sulfatoxymelatonin in 24-hour urine (r = 0.46; P = 0.008; n = 49 subjects). Melatonin levels in serum-plasma pairs had a high correlation (r = 0.97; P < 1x10(-4); n = 20 pairs). Morning serum melatonin levels were five times higher than those from the afterno...Continue Reading

References

Feb 1, 1988·The British Journal of Psychiatry : the Journal of Mental Science·C ThompsonS A Checkley
Jun 1, 1985·The Journal of Clinical Endocrinology and Metabolism·J ArendtV Marks
Jan 15, 1996·American Journal of Epidemiology·P R BandJ Moody
Nov 5, 1997·Journal of Biological Rhythms·A VoultsiosD Dawson
Oct 18, 2001·Journal of the National Cancer Institute·E S SchernhammerG A Colditz
Jun 5, 2003·Journal of the National Cancer Institute·Eva S SchernhammerGraham A Colditz
Aug 18, 2004·Sleep Medicine Reviews·D P Cardinali, P Pévet
Jan 15, 2005·Sleep Medicine Reviews·Josephine Arendt, Debra Jean Skene
Jul 29, 2005·International Journal of Andrology·Philip KumanovMaurizio Nordio
Aug 9, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Sarah P MegdalEva S Schernhammer
Dec 17, 2005·Epidemiology·Eva S SchernhammerSusan E Hankinson
Nov 11, 2006·International Journal of Cancer. Journal International Du Cancer·Yong ZhuTongzhang Zheng
Dec 21, 2006·Epidemiology·Michael ConlonNancy Kreiger
Apr 25, 2007·Breast Cancer Research and Treatment·Yong ZhuTongzhang Zheng
Nov 7, 2007·Prostate Cancer and Prostatic Diseases·L W ChuA W Hsing
Jun 11, 2008·British Journal of Cancer·M KakizakiUNKNOWN Ohsaki Cohort Study
Aug 13, 2008·International Journal of Cancer. Journal International Du Cancer·Tuuli A LahtiEero Pukkala
Sep 25, 2008·British Journal of Cancer·M KakizakiI Tsuji
Feb 14, 2009·Journal of Pineal Research·Thomas C Erren, Russel J Reiter
Dec 1, 2007·The Lancet Oncology·Kurt StraifUNKNOWN WHO International Agency For Research on Cancer Monograph Working Group
Mar 9, 2010·International Journal of Cancer. Journal International Du Cancer·Qiang LiIchiro Tsuji

❮ Previous
Next ❯

Citations

Jan 15, 2014·American Journal of Epidemiology·Xiao-Si WangRuth C Travis
Oct 5, 2012·American Journal of Epidemiology·Marie-Élise ParentJack Siemiatycki
Oct 18, 2011·Cancer Epidemiology·Gianluigi MazzoccoliRobert B Sothern
May 31, 2012·International Journal of Cancer. Journal International Du Cancer·Anna H WuMimi C Yu
Oct 22, 2014·Journal of Ovarian Research·Shavi Fernando, Luk Rombauts
Mar 29, 2019·Journal of Pineal Research·David J Kennaway
Apr 14, 2020·Journal of Pineal Research·David J Kennaway
Oct 28, 2020·Journal of Pineal Research·Jean A Boutin, Ralf Jockers
Apr 28, 2012·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Beata PeplonskaGiske Ursin
Feb 6, 2021·International Journal of Molecular Sciences·Sébastien LalanneSylvie Tordjman
Apr 24, 2021·Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology·David J Kennaway

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of the National Cancer Institute
S DavisR G Stevens
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Dana K Mirick, Scott Davis
Journal of the National Cancer Institute
Eva S SchernhammerG A Colditz
© 2022 Meta ULC. All rights reserved